SUBSCRIBE
SUBSCRIBE

Spark Therapeutics

NEWS
Biogen Idec Alzheimer's Drug Aducanumab Exceeds Expectations
Shire Kills Baxalta’s Hemophilia B Program; Clears Path for BioMarin, Spark Therapeutics and uniQure
August 3, 2016
 · 
3 min read
Astellas Pharma, Proteostasis Therapeutics Forge $1.2 Billion Genetic Disease Drug Development Pact
Job Trends
Spark Therapeutics Expands Into Boston Following One of the Biggest IPOs of the Year
November 4, 2015
 · 
2 min read
Astellas Pharma, Proteostasis Therapeutics Forge $1.2 Billion Genetic Disease Drug Development Pact
Drug Development
Spark Therapeutics Attempts to Quell Investor’s Nerves About Changes to Clinical Trial
September 11, 2015
 · 
2 min read
Here’s Why 5 Billionaire-Led Funds Gobbled Up 3.3 Million Shares of Celldex Stock
Deals
Gene Therapy Biotech Spark Therapeutics Sets Terms for $86 Million IPO
December 31, 2014
 · 
2 min read
Here’s Why 5 Billionaire-Led Funds Gobbled Up 3.3 Million Shares of Celldex Stock
Business
Spark Therapeutics Strikes $280 Million Hemophilia B Pact With Pfizer
December 8, 2014
 · 
2 min read
Load More
AWARDS
  • NextGen Class of 2015
  • 2022 Best Places to Work
JOBS
IN THE PRESS
BioCapital
Spark Therapeutics To Present At The American Society Of Gene & Cell Therapy 2014 Annual Meeting
May 19, 2014
 · 
3 min read
Business
Spark Therapeutics Establishes Permanent Headquarters In West Philadelphia
May 13, 2014
 · 
3 min read
Business
Spark Therapeutics Announces Five Strategic New Hires
April 25, 2014
 · 
2 min read
Business
Spark Therapeutics And Genable Technologies Announce Collaboration To Advance A Gene Therapy Treatment For A Rare Form Of Retinitis Pigmentosa
March 25, 2014
 · 
3 min read
Business
Spark Therapeutics Appoints Industry Leader Dr. Elliott Sigal, Former Executive Vice President And Chief Scientific Officer Of Bristol-Myers Squibb Company, To Board Of Directors
February 11, 2014
 · 
4 min read
Business
Spark Therapeutics Names Dr. Rogerio Vivaldi To Board Of Directors
January 21, 2014
 · 
3 min read
Drug Development
Spark Therapeutics Achieves Recruitment Goal In Phase 3 Gene Therapy Clinical Study For Inherited Blindness
January 14, 2014
 · 
4 min read
Business
Spark Therapeutics Expands Leadership Team To Support Development And Commercialization Of Its Late-Stage Gene Therapy Pipeline
January 9, 2014
 · 
3 min read
Pharm Country
Spark Therapeutics To Present At 32nd Annual J.P. Morgan Healthcare Conference
December 20, 2013
 · 
1 min read
Pharm Country
Spark Therapeutics Launches With $50 Million in Pocket
October 22, 2013
 · 
8 min read
Load More